Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NDX 3324

Next Previous
X
Search
Drug Profile

NDX 3324

Alternative Names: NDX-3324

Latest Information Update: 14 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NexEos Bio
  • Class Imaging agents
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Eosinophilic oesophagitis

Most Recent Events

  • 02 Jan 2024 Phase-I clinical trials in Eosinophilic oesophagitis (Diagnosis, In adults, In adolescents, In children) (unspecified route), prior to January 2024 (NexEos Bio pipeline, January 2024)
  • 02 Jan 2024 NexEos completes type C meeting with the US FDA, prior to January 2024 (NexEos Bio pipeline, January 2024)
  • 02 Jan 2024 US Food and Drug Administration (FDA) approves IND application for NDX 3324 in Eosinophilic esophagitis, prior to January 2024 (NexEos Bio pipeline, January 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top